These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31791288)

  • 21. An evaluation of sodium zirconium cyclosilicate as a treatment option for hyperkalemia.
    Takkar C; Nassar T; Qunibi W
    Expert Opin Pharmacother; 2021 Jan; 22(1):19-28. PubMed ID: 32892634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase 3 multicenter open-label maintenance study to investigate the long-term safety of sodium zirconium cyclosilicate in Japanese subjects with hyperkalemia.
    Kashihara N; Yamasaki Y; Osonoi T; Harada H; Shibagaki Y; Zhao J; Kim H; Yajima T; Sarai N
    Clin Exp Nephrol; 2021 Feb; 25(2):140-149. PubMed ID: 33098526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I Study of the Pharmacodynamics and Safety of Sodium Zirconium Cyclosilicate in Healthy Chinese Adults.
    Cheung T; Sun F; Zhao J; Qin Y; Någård M
    Clin Pharmacol Drug Dev; 2022 Mar; 11(3):348-357. PubMed ID: 34997825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Short-term effect of sodium zirconium cyclosilicate on potassium lowering in chronic kidney disease patients with hyperkalemia].
    Bai C; Shang J; Kang D; Yu W; Zhang FL; Zhang WF; Wu F; Guo RX; Zhang YD; Zhao ZZ
    Zhonghua Yi Xue Za Zhi; 2020 Oct; 100(38):2997-3000. PubMed ID: 33086450
    [No Abstract]   [Full Text] [Related]  

  • 25. A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficient.
    Ash SR; Singh B; Lavin PT; Stavros F; Rasmussen HS
    Kidney Int; 2015 Aug; 88(2):404-11. PubMed ID: 25651363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sodium zirconium cyclosilicate for the management of chronic hyperkalemia in kidney disease, a novel agent.
    Rastogi A; Hanna RM; Mkrttchyan A; Khalid M; Yaqoob S; Shaffer K; Dhawan P; Nobakht N; Kamgar M; Goshtaseb R; Sarmosyan K; Gnarini M; Wassef O; Lerma E
    Expert Rev Clin Pharmacol; 2021 Sep; 14(9):1055-1064. PubMed ID: 34227913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Sodium Zirconium Cyclosilicate on Serum Potassium and Bicarbonate in Patients with Hyperkalemia and Metabolic Acidosis Associated with Chronic Kidney Disease: Rationale and Design of the NEUTRALIZE Study.
    Ash SR; Batlle D; Kendrick J; Oluwatosin Y; Pottorf W; Brahmbhatt Y; Guerrieri E; Fried L
    Nephron; 2022; 146(6):599-609. PubMed ID: 35462371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of hyperkalemia in chronic heart failure using sodium zirconium cyclosilicate.
    Oshima A; Imamura T; Narang N; Kinugawa K
    Clin Cardiol; 2021 Sep; 44(9):1272-1275. PubMed ID: 34263946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sodium Zirconium Cyclosilicate: A Review in Hyperkalaemia.
    Hoy SM
    Drugs; 2018 Oct; 78(15):1605-1613. PubMed ID: 30306338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sodium Zirconium Cyclosilicate (ZS-9): A Novel Agent for the Treatment of Hyperkalemia.
    Linder KE; Krawczynski MA; Laskey D
    Pharmacotherapy; 2016 Aug; 36(8):923-33. PubMed ID: 27393581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the effect of sodium zirconium cyclosilicate on arrhythmia-related cardiovascular outcomes in patients receiving chronic haemodialysis with hyperkalaemia: protocol for the multicentre, randomised, controlled DIALIZE-Outcomes study.
    Fishbane S; Jadoul M; Dember L; Kovesdy CP; Al-Shurbaji A; Lisovskaja V; Sekar P; Katona B; Guzman N; Herzog C
    BMJ Open; 2023 May; 13(5):e071309. PubMed ID: 37230521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potassium-Binding Agents to Facilitate Renin-Angiotensin-Aldosterone System Inhibitor Therapy.
    Schaefer JA; Gales MA
    Ann Pharmacother; 2016 Jun; 50(6):502-10. PubMed ID: 27009290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sodium zirconium cyclosilicate (Lokelma) for hyperkalemia.
    Med Lett Drugs Ther; 2018 Dec; 60(1561):197-199. PubMed ID: 30653476
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of different potassium-lowering regimens on acute hyperkalemia in hemodialysis patients: a real-world, retrospective study.
    Yao L; Xing X; Li Y; Zhang F; Li P; Liang X; Wang P
    J Transl Med; 2022 Jul; 20(1):333. PubMed ID: 35879718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of sodium zirconium cyclosilicate on sodium and potassium excretion in healthy adults: a Phase 1 study.
    Någård M; Singh B; Boulton DW
    Clin Kidney J; 2021 Aug; 14(8):1924-1931. PubMed ID: 34345416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Real-World Experience of Hyperkalemia Management Using Sodium Zirconium Cyclosilicate in Chronic Hemodialysis: A Multicenter Clinical Audit.
    Qu X; Hua Y; Khan BA
    Cureus; 2023 Sep; 15(9):e45058. PubMed ID: 37829953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sodium polystyrene sulfonate versus sodium zirconium cyclosilicate for the treatment of hyperkalemia in the emergency department.
    Hasara S; Dubey J; Amatea J; Finnigan N
    Am J Emerg Med; 2023 Mar; 65():59-64. PubMed ID: 36586223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of sodium zirconium cyclosilicate for the management of acute and chronic hyperkalemia in children with chronic kidney disease 4-5 and on dialysis.
    Khandelwal P; Shah S; McAlister L; Cleghorn S; King L; Shroff R
    Pediatr Nephrol; 2024 Apr; 39(4):1213-1219. PubMed ID: 37857905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sodium zirconium cyclosilicate: a new potassium binder for the treatment of hyperkalemia.
    Cases A; Gorriz JL
    Drugs Today (Barc); 2018 Oct; 54(10):601-613. PubMed ID: 30398481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacodynamics and pharmacokinetics of sodium zirconium cyclosilicate [ZS-9] in the treatment of hyperkalemia.
    Packham DK; Kosiborod M
    Expert Opin Drug Metab Toxicol; 2016 May; 12(5):567-73. PubMed ID: 26998854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.